Guardant Well being (NASDAQ:GH) Inventory Value Down 3%

Guardant Health logoGuardant Well being, Inc. (NASDAQ:GH – Get Ranking) fell 3% throughout mid-day buying and selling on Friday . The corporate traded as little as $26.00 and final traded at $26.24. 1,150 shares modified arms throughout mid-day buying and selling, a decline of 100% from the common session quantity of two,133,132 shares. The inventory beforehand closed at $27.05.

Wall Avenue Analysts Forecast Development

Quite a lot of brokerages have not too long ago commented on GH. BTIG Analysis reduce their worth goal on shares of Guardant Well being from $80.00 to $60.00 in a analysis report on Friday, December sixteenth. JPMorgan Chase & Co. decreased their worth goal on Guardant Well being from $100.00 to $85.00 and set an “chubby” score for the corporate in a report on Friday, November 18th. Stephens dropped their goal worth on Guardant Well being from $99.00 to $90.00 and set an “chubby” score on the inventory in a report on Monday, November seventh. Craig Hallum initiated protection on Guardant Well being in a analysis be aware on Wednesday, October nineteenth. They issued a “purchase” score and a $88.00 goal worth for the corporate. Lastly, Financial institution of America elevated their worth goal on Guardant Well being from $65.00 to $70.00 in a report on Friday, December sixteenth. One fairness analysis analyst has rated the inventory with a maintain score and fourteen have assigned a purchase score to the corporate. In accordance with knowledge from MarketBeat.com, the inventory at present has a median score of “Reasonable Purchase” and a consensus worth goal of $93.59.

Guardant Well being Buying and selling Up 0.6 %

The corporate has a debt-to-equity ratio of 6.82, a fast ratio of 6.10 and a present ratio of 6.46. The inventory has a market capitalization of $2.79 billion, a price-to-earnings ratio of -4.59 and a beta of 0.64. The enterprise has a fifty day easy shifting common of $43.75 and a 200 day easy shifting common of $47.77.

Need Extra Nice Funding Concepts?

Guardant Well being (NASDAQ:GH – Get Ranking) final launched its quarterly earnings outcomes on Thursday, November third. The corporate reported ($1.58) EPS for the quarter, lacking the consensus estimate of ($1.27) by ($0.31). Guardant Well being has a unfavorable internet margin of 140.58% and a unfavorable return on fairness of 145.58%. The enterprise had income of $117.40 million through the quarter, in comparison with analyst estimates of $118.18 million. As a gaggle, analysis analysts anticipate that Guardant Well being, Inc. will submit -6.39 EPS for the present yr.

Insider Exercise

In different Guardant Well being information, insider Kumud Kalia offered 3,125 shares of Guardant Well being inventory in a transaction on Tuesday, November fifteenth. The inventory was offered at a median worth of $51.87, for a complete worth of $162,093.75. Following the completion of the transaction, the insider now straight owns 20,135 shares of the corporate’s inventory, valued at roughly $1,044,402.45. The sale was disclosed in a authorized submitting with the Securities & Alternate Fee, which is on the market by means of this hyperlink. 5.90% of the inventory is owned by firm insiders.

Hedge Funds Weigh In On Guardant Well being

Hedge funds have not too long ago purchased and offered shares of the corporate. Xponance Inc. lifted its holdings in shares of Guardant Well being by 2.4% through the third quarter. Xponance Inc. now owns 11,639 shares of the corporate’s inventory price $627,000 after buying an extra 269 shares through the interval. Captrust Monetary Advisors raised its place in Guardant Well being by 33.2% through the second quarter. Captrust Monetary Advisors now owns 1,087 shares of the corporate’s inventory valued at $44,000 after buying an extra 271 shares within the final quarter. Commonwealth Fairness Providers LLC lifted its stake in Guardant Well being by 4.9% through the second quarter. Commonwealth Fairness Providers LLC now owns 6,120 shares of the corporate’s inventory price $246,000 after buying an extra 286 shares over the last quarter. Manchester Capital Administration LLC boosted its holdings in shares of Guardant Well being by 43.0% within the third quarter. Manchester Capital Administration LLC now owns 965 shares of the corporate’s inventory valued at $52,000 after buying an extra 290 shares within the final quarter. Lastly, Baird Monetary Group Inc. elevated its stake in shares of Guardant Well being by 2.1% within the third quarter. Baird Monetary Group Inc. now owns 14,580 shares of the corporate’s inventory valued at $785,000 after buying an extra 296 shares over the last quarter. 90.43% of the inventory is owned by institutional traders.

Guardant Well being Firm Profile

(Get Ranking)

Guardant Well being, Inc, a precision oncology firm, offers blood exams, knowledge units, and analytics in the US and internationally. The corporate gives Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based exams for superior stage most cancers; and GuardantINFORM, an in-silico analysis platform that contains a clinical-genomic liquid biopsy dataset of superior most cancers sufferers.

See Additionally

Obtain Information & Rankings for Guardant Well being Every day – Enter your e-mail deal with beneath to obtain a concise every day abstract of the newest information and analysts’ rankings for Guardant Well being and associated firms with MarketBeat.com’s FREE every day e-mail publication.